A detailed history of Staley Capital Advisers Inc transactions in Vyne Therapeutics Inc. stock. As of the latest transaction made, Staley Capital Advisers Inc holds 36,472 shares of VYNE stock, worth $66,014. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,472
Previous 36,472 -0.0%
Holding current value
$66,014
Previous $84,000 32.14%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$2.25 - $4.12 $29,250 - $53,560
13,000 Added 55.39%
36,472 $84,000
Q1 2023

May 10, 2023

SELL
$0.14 - $3.87 $5,463 - $151,038
-39,028 Reduced 62.44%
23,472 $72,000
Q4 2021

Feb 08, 2022

BUY
$0.91 - $1.5 $11,375 - $18,750
12,500 Added 25.0%
62,500 $64,000
Q3 2021

Nov 05, 2021

BUY
$1.39 - $3.47 $17,375 - $43,375
12,500 Added 33.33%
50,000 $70,000
Q2 2021

Aug 09, 2021

BUY
$3.24 - $6.92 $40,500 - $86,500
12,500 Added 50.0%
37,500 $132,000
Q1 2021

May 06, 2021

BUY
$6.34 - $12.68 $158,500 - $317,000
25,000 New
25,000 $171,000

Others Institutions Holding VYNE

About VYNE Therapeutics Inc.


  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $105M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Staley Capital Advisers Inc Portfolio

Follow Staley Capital Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Staley Capital Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Staley Capital Advisers Inc with notifications on news.